Literature DB >> 7865594

Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.

T Inamoto1, K Kikuchi, H Iijima, Y Kawashima, Y Nakai, K Ogimoto.   

Abstract

Sixty one strains of Pasteurella multocida and 35 strains of Actinobacillus pleuropneumoniae isolated from pneumonic lesions of porcine lungs during the period from 1985 to 1989 in Japan were tested for antibiotic susceptibility to chlortetracycline (CTC), thiamphenicol (TP), tylosin (TS), acetylisovaleryl-tylosin (AIV-TS), tilmicosin (TMS), mirosamycin (MRM). Most strains of both species were sensitive to CTC, TP and TMS. Growth of fifty-one strains (83.6%) and forty-six strains (75.4%) of P. multocida were inhibited with 3.13 micrograms/ml of CTC and 0.78 micrograms/ml of TP, respectively. TS showed low activity against almost all strains (MIC > or = 6.25 micrograms/ml). Fifty-eight (95.1%), twenty-three (37.7%) and fifty (82%) of P. multocida showed MICs of > or = 6.25 micrograms/ml against AIV-TS, TMS and MRM, respectively. The MICs of A. pleuropneumoniae against CTC were less than 1.56 micrograms/ml. Thirty-two strains (91.4%) and 33 strains (94.3%) of A. pleuropneumoniae were inhibited with 3.13 micrograms/ml of TP and TMS respectively. However, TS, AIV-TS and MRM showed low activity against all of A. pleuropneumoniae (MIC > or = 6.25 micrograms/ml). Three different resistance patterns were observed in P. multocida and two in A. pleuropneumoniae isolates, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865594     DOI: 10.1292/jvms.56.917

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  5 in total

1.  OleD Loki as a Catalyst for Tertiary Amine and Hydroxamate Glycosylation.

Authors:  Ryan R Hughes; Khaled A Shaaban; Jianjun Zhang; Hongnan Cao; George N Phillips; Jon S Thorson
Journal:  Chembiochem       Date:  2017-01-09       Impact factor: 3.164

2.  Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae.

Authors:  H Yoshimura; M Takagi; M Ishimura; Y S Endoh
Journal:  Vet Res Commun       Date:  2002-01       Impact factor: 2.459

3.  Serotyping reanalysis of unserotypable Actinobacillus pleuropneumoniae isolates by agar gel diffusion test.

Authors:  Ayako Morioka; Yoko Shimazaki; Mariko Uchiyama; Shoko Suzuki
Journal:  J Vet Med Sci       Date:  2016-01-03       Impact factor: 1.267

4.  In vitro and in vivo Synergistic Effects of Florfenicol and Thiamphenicol in Combination Against Swine Actinobacillus pleuropneumoniae and Pasteurella multocida.

Authors:  Porjai Rattanapanadda; Hung-Chih Kuo; Thomas W Vickroy; Chi-Hsuan Sung; Tirawat Rairat; Tsai-Lu Lin; Sze-Yu Yeh; Chi-Chung Chou
Journal:  Front Microbiol       Date:  2019-10-30       Impact factor: 5.640

5.  Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2.

Authors:  Zhen Dong; Xu-Zheng Zhou; Ji-Chao Sun; Xiao-Bin Meng; Hong-Sheng Li; Fu-Sheng Cheng; Xiao-Juan Wei; Bing Li; Wei-Wei Wang; Ji-Yu Zhang
Journal:  Vet Med Sci       Date:  2019-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.